You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The immunoassay can be used to monitor cancer cell remnants in a patient's body and help determine which patients need less invasive treatment.
The test measures the level of antibodies to the spike protein of the virus and can be used to establish immunity and vaccine efficacy.
The panel, which includes three immunoassays, identifies the infection stage of the Epstein-Barr virus from a blood sample.
News items for the in vitro diagnostics industry for the week of March 22, 2021.
The clinical chemistry and immunochemistry analyzer can now deliver up to 4,400 tests per hour, double its previous capacity.
The analyzer can perform up to 870 tests per hour and can run Roche's full menu of clinical chemistry and immunochemistry assays.
Roche Diagnostics CEO Thomas Schinecker said the infrastructure put in place due to the pandemic will allow for more diagnostic testing globally.
Under the acquisition agreement, expected to close in Q2, Roche will acquire all outstanding shares of GenMark's common stock for $24.05 per share.
The issues may relate to sporadically leaking assay tubes causing an obstructed optical path in the Cobas Liat analyzer or abnormal PCR cycling in the reaction tubes.
Prequalification from the World Health Organization indicates that products meet high quality standards and are safe for their intended use.